The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Caudell, E. G.
Right arrow Articles by Grimm, E. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Caudell, E. G.
Right arrow Articles by Grimm, E. A.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Substance via MeSH
The Journal of Immunology, 2002, 168: 6041-6046.
Copyright © 2002 by The American Association of Immunologists

The Protein Product of the Tumor Suppressor Gene, Melanoma Differentiation-Associated Gene 7, Exhibits Immunostimulatory Activity and Is Designated IL-241

Eva G. Caudell2,*, John B. Mumm2,*, Nancy Poindexter*, Suhendan Ekmekcioglu*, Abner M. Mhashilkar{dagger}, Xiaohong Helena Yang{dagger}, Mark W. Retter{ddagger}, Paul Hill{ddagger}, Sunil Chada{dagger} and Elizabeth A. Grimm3,*

* Department of Bioimmunotherapy, University of Texas M. D. Anderson Cancer Center, and {dagger} Department of Research, Introgen Therapeutics Inc., Houston, TX 77030; and {ddagger} Corixa Corp., Seattle, WA 98104

The melanoma differentiation-associated gene 7 (mda-7) has been studied primarily in the context of its tumor suppressor activity. Although mda-7 has been designated as IL-24 based on its gene location in the IL-10 locus and its mRNA expression in leukocytes, no functional evidence supporting this cytokine designation exists. To further characterize MDA-7/IL-24 expression patterns in the human immune system, MDA-7/IL-24 protein levels were examined in human PBMC. MDA-7/IL-24 was detected in PHA- and LPS-stimulated whole PBMC lysate by Western blot and in PHA-activated CD56 and CD19 subsets by immunohistochemistry. The biological function of MDA-7/IL-24, secreted from Ad-MDA7-transfected HEK 293 cells, was assessed by examining the effect of MDA-7/IL-24 on the cytokine secretion profile of PBMC. Within 48 h MDA-7/IL-24 induced secretion of high levels of IL-6, TNF-{alpha}, and IFN-{gamma} and low levels of IL-1{beta}, IL-12, and GM-CSF from human PBMC as measured by ELISA. The MDA-7/IL-24-mediated induction of these Th1-type cytokines was inhibited by the addition of IL-10 to the PBMC cultures, suggesting that these two related protein family members may provide antagonistic functions. Therefore, because human blood leukocytes can be stimulated to produce MDA-7/IL-24, as well as respond to MDA-7/IL-24 by expressing secondary cytokines, MDA-7/IL-24 has the expression profile and major functional attributes that justify its designation as an IL.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
K. L. Fuson, M. Zheng, M. Craxton, A. Pataer, R. Ramesh, S. Chada, and R. B. Sutton
Structural Mapping of Post-translational Modifications in Human Interleukin-24: ROLE OF N-LINKED GLYCOSYLATION AND DISULFIDE BONDS IN SECRETION AND ACTIVITY
J. Biol. Chem., October 30, 2009; 284(44): 30526 - 30533.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Andoh, M. Shioya, A. Nishida, S. Bamba, T. Tsujikawa, S. Kim-Mitsuyama, and Y. Fujiyama
Expression of IL-24, an Activator of the JAK1/STAT3/SOCS3 Cascade, Is Enhanced in Inflammatory Bowel Disease
J. Immunol., July 1, 2009; 183(1): 687 - 695.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
M. A. Park, T. Walker, A. P. Martin, J. Allegood, N. Vozhilla, L. Emdad, D. Sarkar, M. Rahmani, M. Graf, A. Yacoub, et al.
MDA-7/IL-24-induced cell killing in malignant renal carcinoma cells occurs by a ceramide/CD95/PERK-dependent mechanism
Mol. Cancer Ther., May 1, 2009; 8(5): 1280 - 1291.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Sainz-Perez, H. Gary-Gouy, F. Gaudin, G. Maarof, A. Marfaing-Koka, T. de Revel, and A. Dalloul
IL-24 Induces Apoptosis of Chronic Lymphocytic Leukemia B Cells Engaged into the Cell Cycle through Dephosphorylation of STAT3 and Stabilization of p53 Expression
J. Immunol., November 1, 2008; 181(9): 6051 - 6060.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Sahoo, Y. M. Jung, H.-K. Kwon, H.-J. Yi, S. Lee, S. Chang, Z.-Y. Park, K.-C. Hwang, and S.-H. Im
A Novel Splicing Variant of Mouse Interleukin (IL)-24 Antagonizes IL-24-induced Apoptosis
J. Biol. Chem., October 24, 2008; 283(43): 28860 - 28872.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
A. Pataer, W. Hu, L. Xiaolin, S. Chada, J. A. Roth, K. K. Hunt, and S. G. Swisher
Adenoviral endoplasmic reticulum-targeted mda-7/interleukin-24 vector enhances human cancer cell killing
Mol. Cancer Ther., August 1, 2008; 7(8): 2528 - 2535.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Sauane, Z.-z. Su, P. Gupta, I. V. Lebedeva, P. Dent, D. Sarkar, and P. B. Fisher
Autocrine regulation of mda-7/IL-24 mediates cancer-specific apoptosis
PNAS, July 15, 2008; 105(28): 9763 - 9768.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
J. Luo, Q. Xia, R. Zhang, C. Lv, W. Zhang, Y. Wang, Q. Cui, L. Liu, R. Cai, and C. Qian
Treatment of Cancer with a Novel Dual-Targeted Conditionally Replicative Adenovirus Armed with mda-7/IL-24 Gene
Clin. Cancer Res., April 15, 2008; 14(8): 2450 - 2457.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
A. Yacoub, M. A. Park, P. Gupta, M. Rahmani, G. Zhang, H. Hamed, D. Hanna, D. Sarkar, I. V. Lebedeva, L. Emdad, et al.
Caspase-, cathepsin-, and PERK-dependent regulation of MDA-7/IL-24-induced cell killing in primary human glioma cells
Mol. Cancer Ther., February 1, 2008; 7(2): 297 - 313.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
A. Yacoub, P. Gupta, M. A. Park, M. Rhamani, H. Hamed, D. Hanna, G. Zhang, D. Sarkar, I. V. Lebedeva, L. Emdad, et al.
Regulation of GST-MDA-7 toxicity in human glioblastoma cells by ERBB1, ERK1/2, PI3K, and JNK1-3 pathway signaling
Mol. Cancer Ther., February 1, 2008; 7(2): 314 - 329.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
B. Wu, C. Huang, L. Garcia, A. P. de Leon, J. S. Osornio, M. Bobadilla-del-Valle, L. Ferreira, S. Canizales, P. Small, M. Kato-Maeda, et al.
Unique Gene Expression Profiles in Infants Vaccinated with Different Strains of Mycobacterium bovis Bacille Calmette-Guerin
Infect. Immun., July 1, 2007; 75(7): 3658 - 3664.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. Sarkar, I. V. Lebedeva, Z.-z. Su, E.-S. Park, L. Chatman, N. Vozhilla, P. Dent, D. T. Curiel, and P. B. Fisher
Eradication of Therapy-Resistant Human Prostate Tumors Using a Cancer Terminator Virus
Cancer Res., June 1, 2007; 67(11): 5434 - 5442.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Sauane, P. Gupta, I. V. Lebedeva, Z.-z. Su, D. Sarkar, A. Randolph, K. Valerie, R. V. Gopalkrishnan, and P. B. Fisher
N-Glycosylation of MDA-7/IL-24 Is Dispensable for Tumor Cell-Specific Apoptosis and "Bystander" Antitumor Activity
Cancer Res., December 15, 2006; 66(24): 11869 - 11877.
[Abstract] [Full Text] [PDF]


Home page
Microbiol. Mol. Biol. Rev.Home page
M. A. Garcia, J. Gil, I. Ventoso, S. Guerra, E. Domingo, C. Rivas, and M. Esteban
Impact of Protein Kinase PKR in Cell Biology: from Antiviral to Antiproliferative Action
Microbiol. Mol. Biol. Rev., December 1, 2006; 70(4): 1032 - 1060.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
D. M. Kokkinakis, A. G. Brickner, J. M. Kirkwood, X. Liu, J. E. Goldwasser, A. Kastrama, C. Sander, D. Bocangel, and S. Chada
Mitotic Arrest, Apoptosis, and Sensitization to Chemotherapy of Melanomas by Methionine Deprivation Stress
Mol. Cancer Res., August 1, 2006; 4(8): 575 - 589.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
I. V. Lebedeva, D. Sarkar, Z.-Z. Su, R. V. Gopalkrishnan, M. Athar, A. Randolph, K. Valerie, P. Dent, and P. B. Fisher
Molecular Target-Based Therapy of Pancreatic Cancer
Cancer Res., February 15, 2006; 66(4): 2403 - 2413.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
P. B. Fisher
Is mda-7/IL-24 a "Magic Bullet" for Cancer?
Cancer Res., November 15, 2005; 65(22): 10128 - 10138.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
D. Sarkar, Z.-z. Su, N. Vozhilla, E. S. Park, P. Gupta, and P. B. Fisher
Dual cancer-specific targeting strategy cures primary and distant breast carcinomas in nude mice
PNAS, September 27, 2005; 102(39): 14034 - 14039.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
N. J. Poindexter, E. T. Walch, S. Chada, and E. A. Grimm
Cytokine induction of interleukin-24 in human peripheral blood mononuclear cells
J. Leukoc. Biol., September 1, 2005; 78(3): 745 - 752.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
Y. Oida, B. Gopalan, R. Miyahara, S. Inoue, C. D. Branch, A. M. Mhashilkar, E. Lin, B. N. Bekele, J. A. Roth, S. Chada, et al.
Sulindac enhances adenoviral vector expressing mda-7/IL-24-mediated apoptosis in human lung cancer
Mol. Cancer Ther., February 1, 2005; 4(2): 291 - 304.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. M. Kokkinakis, X. Liu, S. Chada, M. M. Ahmed, M. M. Shareef, U. K. Singha, S. Yang, and J. Luo
Modulation of Gene Expression in Human Central Nervous System Tumors under Methionine Deprivation-induced Stress
Cancer Res., October 15, 2004; 64(20): 7513 - 7525.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Aggarwal, Y. Takada, A. M. Mhashilkar, K. Sieger, S. Chada, and B. B. Aggarwal
Melanoma Differentiation-Associated Gene-7/IL-24 Gene Enhances NF-{kappa}B Activation and Suppresses Apoptosis Induced by TNF
J. Immunol., October 1, 2004; 173(7): 4368 - 4376.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
N. W. Bartlett, L. Dumoutier, J.-C. Renauld, S. V. Kotenko, C. E. McVey, H.-J. Lee, and G. L. Smith
A new member of the interleukin 10-related cytokine family encoded by a poxvirus
J. Gen. Virol., June 1, 2004; 85(6): 1401 - 1412.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. Ramesh, A. M. Mhashilkar, F. Tanaka, Y. Saito, C. D. Branch, K. Sieger, J. B. Mumm, A. L. Stewart, A. Boquio, L. Dumoutier, et al.
Melanoma Differentiation-associated Gene 7/Interleukin (IL)-24 Is a Novel Ligand That Regulates Angiogenesis via the IL-22 Receptor
Cancer Res., August 15, 2003; 63(16): 5105 - 5113.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
A. Yacoub, C. Mitchell, A. Lister, I. V. Lebedeva, D. Sarkar, Z.-Z. Su, C. Sigmon, R. McKinstry, V. Ramakrishnan, L. Qiao, et al.
Melanoma Differentiation-associated 7 (Interleukin 24) Inhibits Growth and Enhances Radiosensitivity of Glioma Cells in Vitro and in Vivo
Clin. Cancer Res., August 1, 2003; 9(9): 3272 - 3281.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
S. Ekmekcioglu, J. A. Ellerhorst, J. B. Mumm, M. Zheng, L. Broemeling, V. G. Prieto, A. L. Stewart, A. M. Mhashilkar, S. Chada, and E. A. Grimm
Negative Association of Melanoma Differentiation-associated Gene (mda-7) and Inducible Nitric Oxide Synthase (iNOS) in Human Melanoma: MDA-7 Regulates iNOS Expression in Melanoma Cells
Mol. Cancer Ther., January 1, 2003; 2(1): 9 - 17.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.